The University of Chicago Header Logo

Connection

Michael Quinn to Neoplasms

This is a "connection" page, showing publications Michael Quinn has written about Neoplasms.
Connection Strength

0.195
  1. Cancer trends in the United States--a view from Europe. J Natl Cancer Inst. 2003 Sep 03; 95(17):1258-61.
    View in: PubMed
    Score: 0.081
  2. Cancer mortality trends in the EU and acceding countries up to 2015. Ann Oncol. 2003 Jul; 14(7):1148-52.
    View in: PubMed
    Score: 0.080
  3. Cancer survival in England and Wales at the end of the 20th century. Br J Cancer. 2008 Sep 23; 99 Suppl 1:S2-10.
    View in: PubMed
    Score: 0.029
  4. A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy. Clin Cancer Res. 2005 Mar 01; 11(5):1890-8.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.